Suppr超能文献

亚临床甲状腺功能减退症与骨折风险:系统评价和荟萃分析。

Subclinical thyroid dysfunction and the risk for fractures: a systematic review and meta-analysis.

出版信息

Ann Intern Med. 2014 Aug 5;161(3):189-99. doi: 10.7326/M14-0125.

Abstract

BACKGROUND

Data on the association between subclinical thyroid dysfunction and fractures conflict.

PURPOSE

To assess the risk for hip and nonspine fractures associated with subclinical thyroid dysfunction among prospective cohorts.

DATA SOURCES

Search of MEDLINE and EMBASE (1946 to 16 March 2014) and reference lists of retrieved articles without language restriction.

STUDY SELECTION

Two physicians screened and identified prospective cohorts that measured thyroid function and followed participants to assess fracture outcomes.

DATA EXTRACTION

One reviewer extracted data using a standardized protocol, and another verified data. Both reviewers independently assessed methodological quality of the studies.

DATA SYNTHESIS

The 7 population-based cohorts of heterogeneous quality included 50,245 participants with 1966 hip and 3281 nonspine fractures. In random-effects models that included the 5 higher-quality studies, the pooled adjusted hazard ratios (HRs) of participants with subclinical hyperthyroidism versus euthyrodism were 1.38 (95% CI, 0.92 to 2.07) for hip fractures and 1.20 (CI, 0.83 to 1.72) for nonspine fractures without statistical heterogeneity (P = 0.82 and 0.52, respectively; I2= 0%). Pooled estimates for the 7 cohorts were 1.26 (CI, 0.96 to 1.65) for hip fractures and 1.16 (CI, 0.95 to 1.42) for nonspine fractures. When thyroxine recipients were excluded, the HRs for participants with subclinical hyperthyroidism were 2.16 (CI, 0.87 to 5.37) for hip fractures and 1.43 (CI, 0.73 to 2.78) for nonspine fractures. For participants with subclinical hypothyroidism, HRs from higher-quality studies were 1.12 (CI, 0.83 to 1.51) for hip fractures and 1.04 (CI, 0.76 to 1.42) for nonspine fractures (P for heterogeneity = 0.69 and 0.88, respectively; I2 = 0%).

LIMITATIONS

Selective reporting cannot be excluded. Adjustment for potential common confounders varied and was not adequately done across all studies.

CONCLUSION

Subclinical hyperthyroidism might be associated with an increased risk for hip and nonspine fractures, but additional large, high-quality studies are needed.

PRIMARY FUNDING SOURCE

Swiss National Science Foundation.

摘要

背景

亚临床甲状腺功能障碍与骨折之间的关联的数据存在冲突。

目的

评估前瞻性队列中亚临床甲状腺功能障碍与髋部和非脊柱骨折风险的相关性。

资料来源

对 MEDLINE 和 EMBASE(1946 年至 2014 年 3 月 16 日)进行检索,并对检索到的文章的参考文献列表进行无语言限制的检索。

研究选择

两名医生筛选并确定了前瞻性队列,这些队列测量了甲状腺功能,并随访参与者以评估骨折结局。

数据提取

一名审查员使用标准化方案提取数据,另一名审查员验证数据。两名审查员均独立评估了研究的方法学质量。

数据综合

纳入了 7 项混杂质量的人群队列研究,共有 50245 名参与者,发生了 1966 例髋部骨折和 3281 例非脊柱骨折。在包含 5 项高质量研究的随机效应模型中,亚临床甲状腺功能亢进症患者与甲状腺功能正常患者相比,髋部骨折的校正后危险比(HR)为 1.38(95%CI,0.92 至 2.07),非脊柱骨折的校正后 HR 为 1.20(CI,0.83 至 1.72),无统计学异质性(P=0.82 和 0.52;I2=0%)。7 项队列的汇总估计值分别为髋部骨折 1.26(CI,0.96 至 1.65)和非脊柱骨折 1.16(CI,0.95 至 1.42)。当排除甲状腺素治疗者后,亚临床甲状腺功能亢进症患者的髋部骨折 HR 为 2.16(CI,0.87 至 5.37),非脊柱骨折 HR 为 1.43(CI,0.73 至 2.78)。对于亚临床甲状腺功能减退症患者,高质量研究的 HR 为髋部骨折 1.12(CI,0.83 至 1.51),非脊柱骨折 1.04(CI,0.76 至 1.42)(P 异质性=0.69 和 0.88;I2=0%)。

局限性

可能存在选择性报告偏倚。潜在混杂因素的调整在所有研究中各不相同,且调整不充分。

结论

亚临床甲状腺功能亢进症可能与髋部和非脊柱骨折的风险增加相关,但还需要开展更多大型、高质量的研究。

主要资金来源

瑞士国家科学基金会。

相似文献

3
Subclinical thyroid dysfunction and fracture risk: a meta-analysis.
JAMA. 2015 May 26;313(20):2055-65. doi: 10.1001/jama.2015.5161.
4
Cephalomedullary nails versus extramedullary implants for extracapsular hip fractures in older adults.
Cochrane Database Syst Rev. 2022 Jan 26;1(1):CD000093. doi: 10.1002/14651858.CD000093.pub6.
6
Surgical interventions for treating intracapsular hip fractures in older adults: a network meta-analysis.
Cochrane Database Syst Rev. 2022 Feb 14;2(2):CD013404. doi: 10.1002/14651858.CD013404.pub2.
7
Iodine supplementation for women during the preconception, pregnancy and postpartum period.
Cochrane Database Syst Rev. 2017 Mar 5;3(3):CD011761. doi: 10.1002/14651858.CD011761.pub2.
8
Subclinical thyroid dysfunction and the risk of stroke: a systematic review and meta-analysis.
Eur J Epidemiol. 2014 Nov;29(11):791-800. doi: 10.1007/s10654-014-9946-8. Epub 2014 Sep 2.
9
Ultrasound and shockwave therapy for acute fractures in adults.
Cochrane Database Syst Rev. 2014 Jun 23;2014(6):CD008579. doi: 10.1002/14651858.CD008579.pub3.
10
Surgical interventions for treating extracapsular hip fractures in older adults: a network meta-analysis.
Cochrane Database Syst Rev. 2022 Feb 10;2(2):CD013405. doi: 10.1002/14651858.CD013405.pub2.

引用本文的文献

1
4
The relationship of hip fracture and thyroid disorders: a systematic review.
Front Endocrinol (Lausanne). 2023 Oct 10;14:1230932. doi: 10.3389/fendo.2023.1230932. eCollection 2023.
5
Evaluation and Management of Bone Health in Patients with Thyroid Diseases: A Position Statement of the Korean Thyroid Association.
Endocrinol Metab (Seoul). 2023 Apr;38(2):175-189. doi: 10.3803/EnM.2023.1701. Epub 2023 Apr 27.
6
7
CD11c B Cells Participate in the Pathogenesis of Graves' Disease by Secreting Thyroid Autoantibodies and Cytokines.
Front Immunol. 2022 Mar 21;13:836347. doi: 10.3389/fimmu.2022.836347. eCollection 2022.
9
Decision Making in Subclinical Thyroid Disease.
Med Clin North Am. 2021 Nov;105(6):1033-1045. doi: 10.1016/j.mcna.2021.05.014. Epub 2021 Sep 7.
10
Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data.
Osteoporos Int. 2021 Dec;32(12):2543-2553. doi: 10.1007/s00198-021-06032-z. Epub 2021 Jul 31.

本文引用的文献

1
Random-effects meta-analysis of inconsistent effects: a time for change.
Ann Intern Med. 2014 Feb 18;160(4):267-70. doi: 10.7326/M13-2886.
2
The Rotterdam Study: 2014 objectives and design update.
Eur J Epidemiol. 2013 Nov;28(11):889-926. doi: 10.1007/s10654-013-9866-z. Epub 2013 Nov 21.
3
Does thyroid function influence fracture risk? Prospective data from the HUNT2 study, Norway.
Eur J Endocrinol. 2013 Oct 23;169(6):845-52. doi: 10.1530/EJE-13-0546. Print 2013 Dec.
4
Clinical review: A review of the clinical consequences of variation in thyroid function within the reference range.
J Clin Endocrinol Metab. 2013 Sep;98(9):3562-71. doi: 10.1210/jc.2013-1315. Epub 2013 Jul 3.
5
Subclinical hypothyroidism and cardiovascular risk: how to end the controversy.
J Clin Endocrinol Metab. 2013 Jun;98(6):2267-9. doi: 10.1210/jc.2013-1875. Epub 2013 Apr 30.
6
Epidemiology of falls and osteoporotic fractures: a systematic review.
Clinicoecon Outcomes Res. 2013;5:9-18. doi: 10.2147/CEOR.S38721. Epub 2012 Dec 28.
7
8
Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts.
Circulation. 2012 Aug 28;126(9):1040-9. doi: 10.1161/CIRCULATIONAHA.112.096024. Epub 2012 Jul 19.
9
Subclinical hyperthyroidism and the risk of coronary heart disease and mortality.
Arch Intern Med. 2012 May 28;172(10):799-809. doi: 10.1001/archinternmed.2012.402.
10
Clinical review. Risk factors for low bone mass-related fractures in men: a systematic review and meta-analysis.
J Clin Endocrinol Metab. 2012 Jun;97(6):1861-70. doi: 10.1210/jc.2011-3058. Epub 2012 Mar 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验